Synthetic MR AB (LTS:0G79) Cyclically Adjusted Revenue per Share: kr24.10 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0G79 Synthetic MR AB LTS:0G79
61 GF Score
Price kr16.23
GF Value kr126.01
! 3 Warning Signs
View Full Analysis

What is Synthetic MR AB Cyclically Adjusted Revenue per Share?

Synthetic MR AB LTS:0G79 61 Cyclically Adjusted Revenue per Share is kr24.10 as of Mar. 2026. GuruFocus rates LTS:0G79 with a GF Score™ of 61/100 and a GF Value™ of kr126.01. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Synthetic MR AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr0.173. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr24.10 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Synthetic MR AB's average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-27), Synthetic MR AB's current stock price is kr16.23222. Synthetic MR AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr24.10. Synthetic MR AB's Cyclically Adjusted PS Ratio of today is 0.67.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Synthetic MR AB was 21.02. The lowest was 0.46. And the median was 2.85.


Synthetic MR AB  (LTS:0G79) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Synthetic MR AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16.23222/24.10
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Synthetic MR AB was 21.02. The lowest was 0.46. And the median was 2.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Synthetic MR AB Cyclically Adjusted Revenue per Share Related Terms


Synthetic MR AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Synthetic MR AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthetic MR AB Cyclically Adjusted Revenue per Share Chart

Synthetic MR AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 5.00 16.63

Synthetic MR AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.65 6.28 9.06 16.63 24.10

LTS:0G79 vs VEEV, BTSG, HQY: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Synthetic MR AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Cyclically Adjusted PS Ratio falls into.


LTS:0G79
61GF Score
Synthetic MR AB LTS:0G79
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthetic MR AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synthetic MR AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.173/133.5600*133.5600
=0.173

Current CPI (Mar. 2026) = 133.5600.

Synthetic MR AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.077 101.019 0.102
201609 0.079 101.138 0.104
201612 0.197 102.022 0.258
201703 0.199 102.022 0.261
201706 0.122 102.752 0.159
201709 0.166 103.279 0.215
201712 0.284 103.793 0.365
201803 0.230 103.962 0.295
201806 0.241 104.875 0.307
201809 0.243 105.679 0.307
201812 0.331 105.912 0.417
201903 0.222 105.886 0.280
201906 0.280 106.742 0.350
201909 0.260 107.214 0.324
201912 0.229 107.766 0.284
202003 0.271 106.563 0.340
202006 0.214 107.498 0.266
202009 0.228 107.635 0.283
202012 0.342 108.296 0.422
202103 0.318 108.360 0.392
202106 0.247 108.928 0.303
202109 0.294 110.338 0.356
202112 0.398 112.486 0.473
202203 0.214 114.825 0.249
202206 0.402 118.384 0.454
202209 0.406 122.296 0.443
202212 0.427 126.365 0.451
202303 0.339 127.042 0.356
202306 0.446 129.407 0.460
202309 0.456 130.224 0.468
202312 0.671 131.912 0.679
202403 0.396 132.205 0.400
202406 0.266 132.716 0.268
202409 0.270 132.304 0.273
202412 0.281 132.987 0.282
202503 0.259 132.825 0.260
202506 0.231 133.699 0.231
202509 0.196 133.480 0.196
202512 0.280 133.390 0.280
202603 0.173 133.560 0.173

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr24.10 mean?
Synthetic MR AB (LTS:0G79) has a Cyclically Adjusted Revenue per Share of kr24.10 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Synthetic MR AB and its competitors.
Is Synthetic MR AB's Cyclically Adjusted Revenue per Share too high?
Synthetic MR AB's current Cyclically Adjusted Revenue per Share is kr24.10. Overall, Synthetic MR AB has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
Synthetic MR AB's Cyclically Adjusted Revenue per Share of kr24.10 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Synthetic MR AB and its competitors. Synthetic MR AB's current Cyclically Adjusted Revenue per Share is kr24.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Synthetic MR AB (LTS:0G79) has a current Cyclically Adjusted Revenue per Share of kr24.10. The stock's GF Value™ is kr126.01, compared to a current price of kr16.23 — trading 87.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr24.10. Synthetic MR AB's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Synthetic MR AB (LTS:0G79), the current Cyclically Adjusted Revenue per Share is kr24.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthetic MR AB (LTS:0G79) Overvalued in 2026?

Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued. The current stock price of kr16.23 is trading 87.1% below its estimated GF Value™ of kr126.01.

Key valuation signals for LTS:0G79:

  • Cyclically Adjusted Revenue per Share: kr24.10
  • GF Value™: kr126.01 vs. price of kr16.23 (87.1% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the LTS:0G79 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthetic MR AB Business Description

Other Exchanges SYNT:Sweden9480:Germany
Address Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
61GF Score

Get the complete analysis for LTS:0G79

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr16.23
Price
kr126.01
GF Value